Rucha Patil: Privilege to Speak at the West Bengal Hemophilia Conclave 2026 on HTA in Hemophilia Therapies
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”It was a privilege to speak at the West Bengal Hemophilia Conclave 2026, held on 4 July 2026 at Taj Taal Kutir, Kolkata.
I had the opportunity to deliver a lecture on ‘Cost-effectiveness and Health Technology Assessment (HTA) in Hemophilia Therapies: The ICMR Perspective,’ highlighting the role of evidence-based evaluation in improving access to sustainable hemophilia care in India.
My sincere thanks to the Program Director, Prof. (Dr.) Maitreyee Bhattacharyya, for the kind invitation. It was an honour to have the session chaired by the eminent Dr. Prakas Kumar Mandal and Dr. Madhumita Nandi.”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health